Abstract
Ortho Pharmaceutical Corporation's automation of the Drug Safety Evaluation area involves a distributed computer system. Microcomputers are used for data collection and local report generation. A minicomputer serves as the host machine for scheduling and monitoring data collection activities, and houses the centralized study databases. Data can be transferred from the minicomputer to a mainframe computer for statistical analyses. The following major system components were developed internally by Ortho: a Protocol System, a Clinical Pathology System, an In-Life General Toxicology System, and the communications software. Those facets acquired from vendors include a Necropsy/Pathology System (Beckman TOXSYS) and a Reproductive Toxicology/Teratology System (SAIC TEROS). All internal systems development made use of structured analysis, design, programming, and testing techniques. Those systems acquired externally were subjected to rigorous testing and validation prior to acceptance. The Ortho Drug Safety Evaluation automated system is now operational and is running in production mode in the Preclinical Research and Development division.
Get full access to this article
View all access options for this article.
